Skip to main content
Juan Frias, MD, Endocrinology, Los Angeles, CA, Jennifer Moreno Department of Veterans Affairs Medical Center

JuanPabloFriasMD

Endocrinology Los Angeles, CA

Diabetes, Lipid Metabolism, Obesity

Medical Director and Principal Investigator, National Research Institute

Dr. Frias is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Frias' full profile

Already have an account?

Summary

  • Dr. Juan Frias is an endocrinologist in Los Angeles, CA and is affiliated with VA San Diego Healthcare System. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 28 years. He specializes in diabetes and lipid metabolism.

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 1999
  • University of Tennessee
    University of TennesseeResidency, Internal Medicine, 1995 - 1997
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 1994 - 1995
  • US Naval Hospital
    US Naval HospitalInternship, Internal Medicine, 1989 - 1990
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1989

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1997 - 2025
  • FL State Medical License
    FL State Medical License 1991 - 2014
  • CO State Medical License
    CO State Medical License 2001 - 2003
  • TN State Medical License
    TN State Medical License 1995 - 1997

Awards, Honors, & Recognition

  • Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Noninvasive Liver Screening Technology Enables Providers to Detect Liver Disease in Asymptomatic Patients, Identify at-Risk Patients for Referral
    Noninvasive Liver Screening Technology Enables Providers to Detect Liver Disease in Asymptomatic Patients, Identify at-Risk Patients for ReferralJune 9th, 2022
  • Echosens Underscores Impact of Obesity in Nonalcoholic Fatty Liver Disease & Metabolic Syndrome, Emphasizes Role of FibroScan to Monitor Liver Stiffness and Fat at Point-of-Care
    Echosens Underscores Impact of Obesity in Nonalcoholic Fatty Liver Disease & Metabolic Syndrome, Emphasizes Role of FibroScan to Monitor Liver Stiffness and Fat at Point-of-CareSeptember 15th, 2021
  • SURPASS-3: Tirzepatide Superior to Basal Insulin for HbA1c, Body Weight Reduction
    SURPASS-3: Tirzepatide Superior to Basal Insulin for HbA1c, Body Weight ReductionAugust 10th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations